ZA877901B - Active compounds for use in the treatment of tumors - Google Patents

Active compounds for use in the treatment of tumors

Info

Publication number
ZA877901B
ZA877901B ZA877901A ZA877901A ZA877901B ZA 877901 B ZA877901 B ZA 877901B ZA 877901 A ZA877901 A ZA 877901A ZA 877901 A ZA877901 A ZA 877901A ZA 877901 B ZA877901 B ZA 877901B
Authority
ZA
South Africa
Prior art keywords
tumors
treatment
active compounds
hand
devapamil
Prior art date
Application number
ZA877901A
Other languages
English (en)
Inventor
Rolf Kretzschmar
Kretzschmar Rolf
Erich Schlick
Schlick Erich
Michel Eichelbaum
Eichelbaum Michel
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA877901B publication Critical patent/ZA877901B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA877901A 1986-10-22 1987-10-21 Active compounds for use in the treatment of tumors ZA877901B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863635930 DE3635930A1 (de) 1986-10-22 1986-10-22 Wirkstoffe zur anwendung bei der behandlung von tumoren

Publications (1)

Publication Number Publication Date
ZA877901B true ZA877901B (en) 1989-06-28

Family

ID=6312239

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA877901A ZA877901B (en) 1986-10-22 1987-10-21 Active compounds for use in the treatment of tumors

Country Status (8)

Country Link
US (1) US5057304A (xx)
EP (1) EP0268100B1 (xx)
JP (1) JPH0780767B2 (xx)
AT (1) ATE64300T1 (xx)
AU (1) AU604064B2 (xx)
DE (2) DE3635930A1 (xx)
MX (1) MX9203405A (xx)
ZA (1) ZA877901B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635931A1 (de) * 1986-10-22 1988-04-28 Basf Ag Wirkstoffe zur verhuetung von tumormetastasen
DE3710806A1 (de) * 1987-03-31 1988-10-27 Basf Ag Wirkstoff zur tumorbekaempfung
DE3939372A1 (de) * 1989-11-29 1991-06-06 Knoll Ag Mitonafide-infusionsloesung
JPH04182427A (ja) * 1990-11-16 1992-06-30 Meiji Seika Kaisha Ltd キサントシリンxジメチルエーテルを含有する抗腫瘍剤
US6911216B1 (en) 1994-10-12 2005-06-28 Genzyme Corporation Targeted delivery via biodegradable polymers
GB9616504D0 (en) * 1996-08-06 1996-09-25 Chiroscience Ltd Therapeutic product and its use
DE19711503C1 (de) 1997-03-19 1998-09-10 Deutsches Krebsforsch Pharmazeutische Zusammensetzung zur Aufhebung der membranvermittelten Resistenz von Zellen
CA2288876A1 (en) * 1997-05-06 1998-11-12 Xiao Yu Wu Drug delivery system
DE19925810A1 (de) * 1999-06-07 2000-12-14 Paz Arzneimittelentwicklung Anwendung von Verapamil und Verapamilderivaten zur Herstellung von Arzneimitteln mit Glucuronidase hemmender Wirkung
US7423008B2 (en) 2004-03-01 2008-09-09 University Of Kentucky Research Foundation Derivatives of mithramycin and methods of making and uses thereof
US20160067241A1 (en) * 2013-06-13 2016-03-10 Dennis M. Brown Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted naphthalimides such as amonafide for the treatment of immunological, metabolic, infectious, and benign or neoplastic hyperproliferative disease conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE2059923C3 (de) * 1970-12-05 1979-01-25 Knoll Ag, 6700 Ludwigshafen l-a-Isopropyl-o-[(N-methyl-N-homoveratryl)v-aminopropyl] -3,4-dimethoxyphenylacetonitril, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE2059985C3 (de) * 1970-12-05 1979-10-04 Knoll Ag, 6700 Ludwigshafen Rechtsdrehende, basisch substituierte Phenylacetonitrile, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS5883624A (ja) * 1981-11-12 1983-05-19 Eisai Co Ltd 制癌効果増強剤
DE3344755A1 (de) * 1983-12-10 1985-06-20 Basf Ag, 6700 Ludwigshafen 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten
JPH0753665B2 (ja) * 1984-04-20 1995-06-07 財団法人癌研究会 抗転移剤
DE3635931A1 (de) * 1986-10-22 1988-04-28 Basf Ag Wirkstoffe zur verhuetung von tumormetastasen

Also Published As

Publication number Publication date
AU7999787A (en) 1988-04-28
US5057304A (en) 1991-10-15
JPH0780767B2 (ja) 1995-08-30
DE3635930A1 (de) 1988-04-28
ATE64300T1 (de) 1991-06-15
DE3770766D1 (de) 1991-07-18
EP0268100A1 (de) 1988-05-25
MX9203405A (es) 1992-08-31
JPS63104918A (ja) 1988-05-10
EP0268100B1 (de) 1991-06-12
AU604064B2 (en) 1990-12-06

Similar Documents

Publication Publication Date Title
AU704393C (en) Methods for administration of taxol
EP0230575A3 (de) Arzneimittel mit Antitumorwirkung das Hexadecylphosphocholin enthält
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
DE2861089D1 (en) Dihydropyridazones, their preparation and medicines containing them and dihydropyridazones for use in medical treatments
GR3006089T3 (xx)
ZA877901B (en) Active compounds for use in the treatment of tumors
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
ES8801505A1 (es) Procedimiento para preparar sulfuros heterociclicos
AU4620685A (en) Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
EP0315536A3 (fr) Esters polyaromatiques d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
EP0173145A3 (en) Reduction of the toxic effects caused by anthraquinone drugs
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
EP0282844A3 (en) Use of dopamine-agonists in the preparation of a medicament for the treatment of bone injuries
IT1218656B (it) Impiego di composti aventi attivita' mitogena in terapia citostatica